Table of Contents
Lung Cancer International
Volume 2017 (2017), Article ID 2782590, 8 pages
Research Article

Life Expectancy in Pleural and Peritoneal Mesothelioma

Life Expectancy Project, San Francisco, CA, USA

Correspondence should be addressed to Robert Shavelle

Received 9 November 2016; Revised 22 December 2016; Accepted 10 January 2017; Published 23 January 2017

Academic Editor: Akira Iyoda

Copyright © 2017 Robert Shavelle et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Mesothelioma is a rare cancer with a historically dire prognosis. We sought to calculate life expectancies for patients with pleural or peritoneal mesothelioma, both at time of diagnosis and several years later, and to examine whether survival has improved in recent years. Methods. Data on 10,258 pleural and 1,229 peritoneal patients from the SEER US national cancer database, 1973–2011, were analyzed using the Cox proportional hazards regression model. Results. The major factors related to survival were age, sex, stage, grade, histology, and treatment. Survival improved only modestly over the study period: 0.5% per year for pleural and 2% for peritoneal. Conclusions. Life expectancies were markedly reduced from normal, even amongst 5-year survivors with the most favorable characteristics and treatment options.